Vendor, Atlanta, GA
Micron Biomedical Inc.
UEI GVDQTJJNTUN6, CAGE 7P0C5
2 awards and $2,120,007 obligated between June 24, 2026 and September 1, 2026, 50% under full and open competition, against 9.5 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $1,499,999 |
| Centers for Disease Control and Prevention | $620,008 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Not Competed | 1 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93026C00009Definitive Contract, June 24, 2026, Full and Open Competition, 18 offers | National Institutes of Health NiaidNational Institutes of Health | Development of Radiation/Nuclear Medical Countermeasures (Mcms) and Biodosimetry Devices. 7/1/2026 to 6/30/2027. Dap-Ncap-00000073.NAICS 541714, PSC AN12 | $1,499,999 |
| 75D30126C21502Definitive Contract, September 1, 2026, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Manufacturing of a Dissolving Microneedle Patch to Administer Rotavirus VaccineNAICS 541715, PSC B599 | $620,008 |
- Places of performance
- Georgia
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchB599 Other Special Studies and Analysis
- Transactions
- 2 across 2 awards